Identifying determinants of bacterial fitness in a model of human gut microbial succession.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
04 02 2020
Historique:
pubmed: 24 1 2020
medline: 17 6 2020
entrez: 24 1 2020
Statut: ppublish

Résumé

Human gut microbiota development has been associated with healthy growth but understanding the determinants of community assembly and composition is a formidable challenge. We cultured bacteria from serially collected fecal samples from a healthy infant; 34 sequenced strains containing 103,102 genes were divided into two consortia representing earlier and later stages in community assembly during the first six postnatal months. The two consortia were introduced alone (singly), or sequentially in different order, or simultaneously into young germ-free mice fed human infant formula. The pattern of fitness of bacterial strains observed across the different colonization conditions indicated that later-phase strains substantially outcompete earlier-phase strains, although four early-phase members persist. Persistence was not determined by order of introduction, suggesting that priority effects are not prominent in this model. To characterize succession in the context of the metabolic potential of consortium members, we performed in silico reconstructions of metabolic pathways involved in carbohydrate utilization and amino acid and B-vitamin biosynthesis, then quantified the fitness (abundance) of strains in serially collected fecal samples and their transcriptional responses to different histories of colonization. Applying feature-reduction methods disclosed a set of metabolic pathways whose presence and/or expression correlates with strain fitness and that enable early-stage colonizers to survive during introduction of later colonizers. The approach described can be used to test the magnitude of the contribution of identified metabolic pathways to fitness in different community contexts, study various ecological processes thought to govern community assembly, and facilitate development of microbiota-directed therapeutics.

Identifiants

pubmed: 31969452
pii: 1918951117
doi: 10.1073/pnas.1918951117
pmc: PMC7007522
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2622-2633

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK056341
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK030292
Pays : United States

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

Competing interest statement: J.I.G. is a cofounder of Matatu, Inc., a company characterizing the role of diet-by-microbiota interactions in animal health.

Références

Cell. 2019 Sep 19;179(1):59-73.e13
pubmed: 31539500
Proc Biol Sci. 1995 Mar 22;259(1356):249-57
pubmed: 7740045
Nature. 2016 May 25;534(7606):263-6
pubmed: 27279225
Science. 2015 Oct 2;350(6256):aac5992
pubmed: 26430127
BMC Genomics. 2008 Feb 08;9:75
pubmed: 18261238
PLoS Biol. 2014 Mar 11;12(3):e1001805
pubmed: 24618695
Sci Transl Med. 2017 May 17;9(390):
pubmed: 28515336
Nature. 2019 May;569(7758):663-671
pubmed: 31142858
Science. 2018 Aug 3;361(6401):469-474
pubmed: 30072533
Nucleic Acids Res. 2005 Oct 07;33(17):5691-702
pubmed: 16214803
Cell. 2009 Aug 21;138(4):774-86
pubmed: 19703402
Genome Biol. 2009;10(3):R25
pubmed: 19261174
Trends Microbiol. 2017 Mar;25(3):217-228
pubmed: 27916383
Nat Rev Microbiol. 2012 Jul 16;10(8):538-50
pubmed: 22796884
PLoS Biol. 2013;11(8):e1001637
pubmed: 23976882
Cell Host Microbe. 2019 May 8;25(5):656-667.e8
pubmed: 31028005
Front Microbiol. 2019 Jun 12;10:1316
pubmed: 31275260
Nature. 2019 May;569(7758):655-662
pubmed: 31142855
Nature. 2018 Oct;562(7728):589-594
pubmed: 30356183
Nature. 2018 Oct;562(7728):583-588
pubmed: 30356187
Cell. 2015 Sep 24;163(1):95-107
pubmed: 26406373
Trends Ecol Evol. 2005 Jun;20(6):345-53
pubmed: 16701391
Science. 2019 Jul 12;365(6449):
pubmed: 31296738
Nature. 2006 Apr 20;440(7087):1007-12
pubmed: 16625187
Science. 2019 Jul 12;365(6449):
pubmed: 31296739
Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):4786-91
pubmed: 22427355
Environ Microbiol. 2013 Oct;15(10):2631-41
pubmed: 23834245

Auteurs

Lihui Feng (L)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Arjun S Raman (AS)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Matthew C Hibberd (MC)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110; jgordon@wustl.edu.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Jiye Cheng (J)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Nicholas W Griffin (NW)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Yangqing Peng (Y)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Semen A Leyn (SA)

A. A. Kharkevich Institute for Information Transmission Problems, Russian Academy of Sciences, 127994 Moscow, Russia.
Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.

Dmitry A Rodionov (DA)

A. A. Kharkevich Institute for Information Transmission Problems, Russian Academy of Sciences, 127994 Moscow, Russia.
Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.

Andrei L Osterman (AL)

Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037.

Jeffrey I Gordon (JI)

Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St. Louis, MO 63110; jgordon@wustl.edu.
Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO 63110.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH